Maryland Settles EpiPen Claims Against Mylan, Inc.

June 29, 2026

On May 4, 2026, Maryland’s Attorney General announced that the Antitrust Division reached a settlement with Mylan Inc. (Mylan), the company that sells the EpiPen®, resolving concerns about anticompetitive conduct involving the cost, marketing, and availability of EpiPen products.  The Ep[...]

Continue Reading

The Meteoric Rise In Prescription Drug Prices

March 28, 2016

The results of a recent study undertaken by Express Scripts, a provider of integrated pharmacy benefit management services in the United States, found that average brand-name prescription drug prices in the United States has risen by 98.2% since 2011. In 2015, brand-name prescription drug prices[...]

Continue Reading

Fungal Meningitis Outbreak

October 7, 2012

On October 6, 2012, the Centers for Disease Control and Prevention (CDC) announced that seven people have died as a result of a fungal meningitis outbreak, and 64 people in 9 U.S. states have been diagnosed with fungal meningitis that are linked to the use of contaminated steroid injections (epidu[...]

Continue Reading

Drug Shortages Are Getting Even Worse!

December 17, 2011

The U.S. Government Accountability Office (GAO) released a report on December 15, 2011 in which it stated that the U.S. Congress should consider requiring drug manufacturers to report to the U.S. Food and Drug Administration (FDA) any changes that could affect their supply of their drugs. The GAO f[...]

Continue Reading